Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Fujii

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 22, 2019
[A Case of Synchronous Diffuse Large B-Cell Lymphoma of the Right Breast and Invasive Ductal Carcinoma of the Left Breast]Tomoki Fujii, Nobuhiro Ohno, Tomoharu Matsui, et al.
Japanese Journal of Clinical Oncology|June 13, 2009
Dose-escalating and pharmacokinetic study of a weekly combination of paclitaxel and carboplatin for inoperable non-small cell lung cancer: JCOG 9910-DIKatsuhiko Naoki, Hiroshi Kunikane, Tomoki Fujii, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 6, 2021
[Successful treatment with imatinib for a patient with myeloid neoplasms with eosinophilia and abnormalities of PDGFRB due to t (5;14)(q33;q22)]Tomoki Fujii, Nobuhiro Ohno, Tomoharu Matsui, et al.
Brachytherapy|July 16, 2023
Analysis of applicator displacement in accelerated partial breast irradiation using a strut-based design brachytherapy applicatorTadashi Kubo, Chie Kurokawa, Tatsuya Inoue, et al.
International Journal of Hematology|February 1, 2026
Synergistic effects of elranatamab and Juzentaihoto, Japanese traditional herbal medicine, in triple-class-exposed relapsed/refractory multiple myeloma with extramedullary disease: a case reportNaohi Sahara, Takashi Matsunaga, Go Chie, et al.
Oncology Letters|April 19, 2024
Daratumumab‑resistant multiple myeloma with extramedullary disease successfully treated with combination elotuzumab, pomalidomide and dexamethasone: A case reportMasataka Sakashita, Naohi Sahara, Jun Aoki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 7, 2022
[Extranodal NK/T cell lymphoma, nasal type with local recurrence in the contralateral nasal cavity 15 years after initial sequential chemoradiotherapy]Tomoki Fujii, Nobuhiro Ohno, Shinsuke Kitahara, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 5, 2023
[Intestinal pneumatosis developed during the treatment of severe gastrointestinal graft-versus-host disease after cord blood transplantation]Yuma Kawamura, Nobuaki Fukushima, Tomoki Fujii, et al.
Blood Cell Therapy|December 27, 2023
Three cases of suspected pleuroparenchymal fibroelastosis after allogeneic hematopoietic cell transplantationShiori Morikawa, Nobuaki Fukushima, Tomoya Arakawa, et al.
Japanese Journal of Clinical Oncology|September 23, 2009
A phase II study of cisplatin and irinotecan as induction chemotherapy followed by accelerated hyperfractionated thoracic radiotherapy with daily low-dose carboplatin in unresectable stage III non-small cell lung cancer: JCOG 9510Tomoki Fujii, Hiroshi Kunikane, Hiroaki Okamoto, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 22, 2019
[A Case of Synchronous Diffuse Large B-Cell Lymphoma of the Right Breast and Invasive Ductal Carcinoma of the Left Breast]Tomoki Fujii, Nobuhiro Ohno, Tomoharu Matsui, et al.
Japanese Journal of Clinical Oncology|June 13, 2009
Dose-escalating and pharmacokinetic study of a weekly combination of paclitaxel and carboplatin for inoperable non-small cell lung cancer: JCOG 9910-DIKatsuhiko Naoki, Hiroshi Kunikane, Tomoki Fujii, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 6, 2021
[Successful treatment with imatinib for a patient with myeloid neoplasms with eosinophilia and abnormalities of PDGFRB due to t (5;14)(q33;q22)]Tomoki Fujii, Nobuhiro Ohno, Tomoharu Matsui, et al.
Brachytherapy|July 16, 2023
Analysis of applicator displacement in accelerated partial breast irradiation using a strut-based design brachytherapy applicatorTadashi Kubo, Chie Kurokawa, Tatsuya Inoue, et al.
International Journal of Hematology|February 1, 2026
Synergistic effects of elranatamab and Juzentaihoto, Japanese traditional herbal medicine, in triple-class-exposed relapsed/refractory multiple myeloma with extramedullary disease: a case reportNaohi Sahara, Takashi Matsunaga, Go Chie, et al.
Oncology Letters|April 19, 2024
Daratumumab‑resistant multiple myeloma with extramedullary disease successfully treated with combination elotuzumab, pomalidomide and dexamethasone: A case reportMasataka Sakashita, Naohi Sahara, Jun Aoki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 7, 2022
[Extranodal NK/T cell lymphoma, nasal type with local recurrence in the contralateral nasal cavity 15 years after initial sequential chemoradiotherapy]Tomoki Fujii, Nobuhiro Ohno, Shinsuke Kitahara, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 5, 2023
[Intestinal pneumatosis developed during the treatment of severe gastrointestinal graft-versus-host disease after cord blood transplantation]Yuma Kawamura, Nobuaki Fukushima, Tomoki Fujii, et al.
Blood Cell Therapy|December 27, 2023
Three cases of suspected pleuroparenchymal fibroelastosis after allogeneic hematopoietic cell transplantationShiori Morikawa, Nobuaki Fukushima, Tomoya Arakawa, et al.
Japanese Journal of Clinical Oncology|September 23, 2009
A phase II study of cisplatin and irinotecan as induction chemotherapy followed by accelerated hyperfractionated thoracic radiotherapy with daily low-dose carboplatin in unresectable stage III non-small cell lung cancer: JCOG 9510Tomoki Fujii, Hiroshi Kunikane, Hiroaki Okamoto, et al.
Pageof 4